Àngels López Last Tuesday, within the framework of the Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER- BBN), IBEC signed an agreement with pharmaceutical company Ferrer and the universities of Valladolid and the Basque Country to work towards developing a stem cell-based therapy to regenerate the surface of the eye.
On October 13 El Periódico published an article about Nobel Prize winners John Gurdon and Shinya Yamanaka, who won the prize in medicine or physiology for their achievements in stem cell research. Towards the end of the piece, the author talks about the leading position held by Catalonia in research into stem cells, naming IBEC’s Ángel Raya as one of the region’s pioneers.
Yesterday saw the launch in Madrid of a new NanoMed Spain publication, ‘Hoja por la Innovación en Nanomedicina en España’ (White Paper on Innovation in Nanomedicine in Spain), which diagnoses the country’s R&D&I capacities in the field so far and presents the potential opportunities, challenges and recommendations for the future.
IBEC group leader Ángel Raya is quoted in articles in online newspapers Público and Materia this week, giving his expert opinion about some recent research in Japan. The scientists in … Read more
IBEC now has its very own YouTube channel, where viewers can watch a host of videos related to the institute and aimed at a variety of audiences.
At the end of September representatives from IBEC, which coordinates and manages the Connect-EU Nanobio+Nanomed group, participated in the Connect-EU conference at Barcelona’s World Trade Centre.
Senior researcher Eduard Torrents appears several times in the July edition of the newspaper of the Associació Catalana de Fibrosi Quística, Per a Vèncer la Fibrosi Quística.
This month, the three candidates selected by the Scientific Advisory Board for IBEC’s new Tenure Track scheme started in their new capacity as Junior Group Leaders.
The IBEC-coordinated European project MySpine, which reached its midpoint at the end of August, received a positive appraisal at its first Annual Review in Brussels in June.
An IBEC researcher has collaborated on a paper published in Nature Nanotechnology that outlines an effective new way to characterize and improve nanoparticle catalysts, which play essential roles in biomedicine, industry and everyday life by affecting the rate at which chemical reactions take place.Nanoparticle catalysts are used in making polymers and biofuels, synthesising new drugs, pollution control devices and fuel cell technology, and both characterising them and finding more effective ones is vital.